ID

42786

Description

Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00113763

Link

https://clinicaltrials.gov/show/NCT00113763

Keywords

Versions (2)
  1. 8/4/16 8/4/16 -
  2. 9/17/21 9/17/21 -
Uploaded on

September 17, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Colorectal Cancer NCT00113763

English

Eligibility Colorectal Cancer NCT00113763

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathologic diagnosis of colorectal adenocarcinoma (diagnostic tissue obtained by tissue biopsy)
Description

Adenocarcinoma of large intestine | biopsy tissue

Data type

boolean

Alias
UMLS CUI [1]
C1319315
UMLS CUI [2]
C3864006
metastatic colorectal carcinoma
Description

Colorectal cancer metastatic

Data type

boolean

Alias
UMLS CUI [1]
C0948380
eastern cooperative oncology group (ecog) performance status of 0, 1 or 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
documented evidence of disease progression during, or following treatment, with fluoropyrimidine, irinotecan and oxaliplatin chemotherapy for metastatic colorectal cancer
Description

Disease Progression Evidence of | Therapeutic procedure | fluoropyrimidine | irinotecan | oxaliplatin | Chemotherapy Colorectal cancer metastatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0332120
UMLS CUI [2]
C0087111
UMLS CUI [3]
C0596581
UMLS CUI [4]
C0123931
UMLS CUI [5]
C0069717
UMLS CUI [6,1]
C0392920
UMLS CUI [6,2]
C0948380
radiographic documentation of disease progression during or within 6 months following the most recent chemotherapy regimen
Description

Disease Progression | radiography | Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C0034571
UMLS CUI [3]
C0392920
unidimensionally measurable disease
Description

Measurable Disease Dimension One

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0439534
UMLS CUI [1,3]
C0205447
tumor expressing epidermal growth factor receptor (egfr) by immunohistochemistry
Description

Malignant Neoplasm | Epidermal Growth Factor Receptor Gene Expression | Immunohistochemistry

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0034802
UMLS CUI [2,2]
C0017262
UMLS CUI [3]
C0021044
at least 2 but not more than 3 prior chemotherapy regimens for colorectal cancer
Description

Prior Chemotherapy Quantity Colorectal Cancer

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0009402
adequate hematologic, renal and hepatic function
Description

Hematologic function | Renal function | Liver function

Data type

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
symptomatic brain metastases requiring treatment
Description

Metastatic malignant neoplasm to brain Symptomatic | Therapeutic procedure Requirement

Data type

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1514873
history or evidence of interstitial pneumonitis or pulmonary fibrosis
Description

Interstitial Pneumonia History | Pulmonary Fibrosis History | Interstitial Pneumonia Evidence of | Pulmonary Fibrosis Evidence of

Data type

boolean

Alias
UMLS CUI [1,1]
C0206061
UMLS CUI [1,2]
C0262926
UMLS CUI [2,1]
C0034069
UMLS CUI [2,2]
C0262926
UMLS CUI [3,1]
C0206061
UMLS CUI [3,2]
C0332120
UMLS CUI [4,1]
C0034069
UMLS CUI [4,2]
C0332120
use of systemic chemotherapy or radiotherapy within 30 days prior to enrollment
Description

Systemic Chemotherapy | Therapeutic radiology procedure Systemic

Data type

boolean

Alias
UMLS CUI [1]
C1883256
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0205373
prior epidermal growth factor receptor (egfr) targeting therapies
Description

Prior Therapy Targeting Epidermal Growth Factor Receptor

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1521840
UMLS CUI [1,3]
C0034802
prior anti-tumor therapies including prior experimental agents or approved anti-tumor small molecules and biologics of short (less than a week) serum half life within 30 days before enrollment, or prior experimental or approved proteins within 3 months before enrollment.
Description

cancer treatment | Investigational New Drugs | Small Molecule Against Malignant Neoplasms | Biological Factors drug biological half life Short | Proteins

Data type

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C0013230
UMLS CUI [3,1]
C1328819
UMLS CUI [3,2]
C0521124
UMLS CUI [3,3]
C0006826
UMLS CUI [4,1]
C0005515
UMLS CUI [4,2]
C0599113
UMLS CUI [4,3]
C1806781
UMLS CUI [5]
C0033684
Back to the top of the page

Similar models

Eligibility Colorectal Cancer NCT00113763

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of large intestine | biopsy tissue
Item
pathologic diagnosis of colorectal adenocarcinoma (diagnostic tissue obtained by tissue biopsy)
boolean
C1319315 (UMLS CUI [1])
C3864006 (UMLS CUI [2])
Colorectal cancer metastatic
Item
metastatic colorectal carcinoma
boolean
C0948380 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0, 1 or 2
boolean
C1520224 (UMLS CUI [1])
Disease Progression Evidence of | Therapeutic procedure | fluoropyrimidine | irinotecan | oxaliplatin | Chemotherapy Colorectal cancer metastatic
Item
documented evidence of disease progression during, or following treatment, with fluoropyrimidine, irinotecan and oxaliplatin chemotherapy for metastatic colorectal cancer
boolean
C0242656 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2])
C0596581 (UMLS CUI [3])
C0123931 (UMLS CUI [4])
C0069717 (UMLS CUI [5])
C0392920 (UMLS CUI [6,1])
C0948380 (UMLS CUI [6,2])
Disease Progression | radiography | Chemotherapy
Item
radiographic documentation of disease progression during or within 6 months following the most recent chemotherapy regimen
boolean
C0242656 (UMLS CUI [1])
C0034571 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
Measurable Disease Dimension One
Item
unidimensionally measurable disease
boolean
C1513041 (UMLS CUI [1,1])
C0439534 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
Malignant Neoplasm | Epidermal Growth Factor Receptor Gene Expression | Immunohistochemistry
Item
tumor expressing epidermal growth factor receptor (egfr) by immunohistochemistry
boolean
C0006826 (UMLS CUI [1])
C0034802 (UMLS CUI [2,1])
C0017262 (UMLS CUI [2,2])
C0021044 (UMLS CUI [3])
Prior Chemotherapy Quantity Colorectal Cancer
Item
at least 2 but not more than 3 prior chemotherapy regimens for colorectal cancer
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0009402 (UMLS CUI [1,3])
Hematologic function | Renal function | Liver function
Item
adequate hematologic, renal and hepatic function
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Metastatic malignant neoplasm to brain Symptomatic | Therapeutic procedure Requirement
Item
symptomatic brain metastases requiring treatment
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
Interstitial Pneumonia History | Pulmonary Fibrosis History | Interstitial Pneumonia Evidence of | Pulmonary Fibrosis Evidence of
Item
history or evidence of interstitial pneumonitis or pulmonary fibrosis
boolean
C0206061 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0034069 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
C0206061 (UMLS CUI [3,1])
C0332120 (UMLS CUI [3,2])
C0034069 (UMLS CUI [4,1])
C0332120 (UMLS CUI [4,2])
Systemic Chemotherapy | Therapeutic radiology procedure Systemic
Item
use of systemic chemotherapy or radiotherapy within 30 days prior to enrollment
boolean
C1883256 (UMLS CUI [1])
C1522449 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
Prior Therapy Targeting Epidermal Growth Factor Receptor
Item
prior epidermal growth factor receptor (egfr) targeting therapies
boolean
C1514463 (UMLS CUI [1,1])
C1521840 (UMLS CUI [1,2])
C0034802 (UMLS CUI [1,3])
cancer treatment | Investigational New Drugs | Small Molecule Against Malignant Neoplasms | Biological Factors drug biological half life Short | Proteins
Item
prior anti-tumor therapies including prior experimental agents or approved anti-tumor small molecules and biologics of short (less than a week) serum half life within 30 days before enrollment, or prior experimental or approved proteins within 3 months before enrollment.
boolean
C0920425 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C1328819 (UMLS CUI [3,1])
C0521124 (UMLS CUI [3,2])
C0006826 (UMLS CUI [3,3])
C0005515 (UMLS CUI [4,1])
C0599113 (UMLS CUI [4,2])
C1806781 (UMLS CUI [4,3])
C0033684 (UMLS CUI [5])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial